Drug Profile
Research programme: neuraminidase inhibitors - AllaChem/ASAVI/ChemDiv
Alternative Names: AV 5027; AV 5075C; Influenza virus neuraminidase inhibitors - AllaChem/ASAVI/ChemDivLatest Information Update: 31 Mar 2020
Price :
$50
*
At a glance
- Originator AllaChem
- Class Acids; Small molecules
- Mechanism of Action Neuraminidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 24 Mar 2020 Viriom, China center for disease control and prevention and Ministry of Health of Russian Federation agree to determine the antiviral activity of Elpida for COVID-19 infections
- 24 Mar 2020 Viriom plans a preclinical and clinical trial for COVID-19 infection in collaboration with China Center for Disease Control and Prevention and the Ministry of Health of the Russian Federation
- 28 Dec 2017 No recent reports of development identified for preclinical development in Influenza-virus-infections in Russia (PO)